Wide ranges of serum myostatin concentrations in Duchenne muscular dystrophy patients

Clinica Chimica Acta

Volumn 391, Issue 1-2, 2008, Pages 115-117

  Awano, Hiroyuki ^a   Takeshima, Yasuhiro ^a   Okizuka, Yo ^a   Saiki, Kayoko ^a   Yagi, Mariko ^a   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSTROPHIN; MESSENGER RNA; MYOSTATIN; PROTEIN INHIBITOR;

CLINICAL FEATURE; DIET THERAPY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FIBROSIS; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE TRANSLOCATION; GENETIC VARIABILITY; HUMAN; LETTER; MUSCLE GROWTH; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; RNA SPLICING; WESTERN BLOTTING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DYSTROPHIN; HUMANS; INFANT; MUSCULAR DYSTROPHY, DUCHENNE; TRANSFORMING GROWTH FACTOR BETA;

EID: 41849145180     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.01.024     Document Type: Letter

References (14)

1. Monaco A.P., Bertelson C.J., Liechti-Gallati S., Moser H., and Kunkel L.M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genom 2 (1988) 90-95
2. Winnard A.V., Klein C.J., Coovert D.D., et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet 2 (1993) 737-744
3. Prior T.W., Bartolo C., Papp A.C., et al. Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion. Neurology 48 (1997) 486-488
4. Hattori N., Kaido M., Nishigaki T., et al. Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy. Neuromuscul Disord 9 (1999) 220-226
5. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 (1997) 83-90
6. McNally E.M. Powerful genes - myostatin regulation of human muscle mass. N Engl J Med 350 (2004) 2642-2644
7. Nishiyama A., Takeshima Y., Saiki K., et al. Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy. BMC Med Genet 8 (2007) 1-9
8. Bogdanovich S., Krag T.O., Barton E.R., et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420 (2002) 418-421
9. Wagner K.R., Liu X., Chang X., and Allen R.E. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A. 102 (2005) 2519-2524
10. Magee T.R., Artaza J.N., Ferrini M.G., et al. Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. J Gene Med 8 (2006) 1171-1181
11. Patel K., and Amthor H. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord 15 (2005) 117-126
12. Zimmers T.A., Davies M.V., Koniaris L.G., et al. Induction of cachexia in mice by systemically administered myostatin. Science 296 (2002) 1486-1488
13. Zanottia S., Saredi S., Ruggieri A., et al. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biol 26 (2007) 615-624
14. Schuelke M., Wagner K.R., Stolz L.E., et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350 (2004) 2682-2688